Alliance Pharma plc (APH) — Net Asset Quality Index
Alliance Pharma plc (APH) has a Net Asset Quality Index of 56.3% as of December 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of GBX369.14 Million minus total liabilities of GBX161.50 Million yields net assets of GBX207.64 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check APH asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Alliance Pharma plc Net Asset Quality Index Over Time (1999–2024)
This chart shows how Alliance Pharma plc's Net Asset Quality Index has evolved across 28 annual periods from 1999 to 2024. As of December 2024, the index stands at 56.3%, representing net assets of GBX207.64 Million against total assets of GBX369.14 Million GBX. See Alliance Pharma plc (APH) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Alliance Pharma plc (1999–2024)
The table below presents the year-by-year Net Asset Quality Index for Alliance Pharma plc from 1999 to 2024, covering 28 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see Alliance Pharma plc stock valuation.
| Year | Quality Index | Net Assets (GBX) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 56.3% | GBX207.64 Million | GBX369.14 Million | GBX161.50 Million | ▲ +3.7 pp |
| 2023 | 52.5% | GBX217.87 Million | GBX414.92 Million | GBX197.05 Million | ▼ -1.0 pp |
| 2022 | 53.5% | GBX287.66 Million | GBX537.41 Million | GBX249.75 Million | ▼ -2.6 pp |
| 2021 | 56.1% | GBX282.49 Million | GBX503.49 Million | GBX221.00 Million | ▲ +0.9 pp |
| 2020 | 55.2% | GBX280.96 Million | GBX508.85 Million | GBX227.90 Million | ▼ -12.0 pp |
| 2019 | 67.3% | GBX274.18 Million | GBX407.64 Million | GBX133.46 Million | ▲ +4.8 pp |
| 2018 | 62.5% | GBX252.20 Million | GBX403.61 Million | GBX151.41 Million | ▲ +2.0 pp |
| 2017 | 60.4% | GBX203.38 Million | GBX336.48 Million | GBX133.10 Million | ▲ +4.6 pp |
| 2016 | 55.9% | GBX179.26 Million | GBX320.74 Million | GBX141.47 Million | ▲ +0.3 pp |
| 2015 | 55.6% | GBX162.44 Million | GBX292.19 Million | GBX129.75 Million | ▼ -10.0 pp |
| 2014 | 65.6% | GBX70.78 Million | GBX107.87 Million | GBX37.09 Million | ▲ +5.2 pp |
| 2013 | 60.4% | GBX64.67 Million | GBX106.99 Million | GBX42.32 Million | ▲ +8.9 pp |
| 2012 | 51.5% | GBX51.85 Million | GBX100.63 Million | GBX48.78 Million | ▼ -2.1 pp |
| 2011 | 53.6% | GBX44.13 Million | GBX82.29 Million | GBX38.16 Million | ▲ +7.0 pp |
| 2010 | 46.6% | GBX36.08 Million | GBX77.40 Million | GBX41.32 Million | ▲ +17.3 pp |
| 2009 | 29.3% | GBX16.63 Million | GBX56.80 Million | GBX40.17 Million | ▲ +11.3 pp |
| 2008 | 17.9% | GBX8.77 Million | GBX48.83 Million | GBX40.07 Million | ▲ +3.6 pp |
| 2007 | 14.4% | GBX6.67 Million | GBX46.41 Million | GBX39.74 Million | ▼ -7.3 pp |
| 2006 | 21.7% | GBX10.43 Million | GBX48.07 Million | GBX37.63 Million | ▲ +0.7 pp |
| 2005 | 21.0% | GBX7.50 Million | GBX35.76 Million | GBX28.26 Million | ▲ +1.1 pp |
| 2005 | 19.9% | GBX6.83 Million | GBX34.30 Million | GBX27.47 Million | ▲ +11.5 pp |
| 2004 | 8.4% | GBX2.23 Million | GBX26.44 Million | GBX24.21 Million | ▲ +9.3 pp |
| 2003 | -0.9% | GBX-194.00K | GBX20.82 Million | GBX21.01 Million | ▼ -99.9 pp |
| 2002 | 98.9% | GBX2.24 Million | GBX2.26 Million | GBX24.11K | ▲ +92.8 pp |
| 2002 | 6.1% | GBX538.00K | GBX8.82 Million | GBX8.29 Million | ▼ -8.8 pp |
| 2001 | 14.9% | GBX595.00K | GBX3.99 Million | GBX3.39 Million | ▲ +4.6 pp |
| 2000 | 10.4% | GBX451.00K | GBX4.35 Million | GBX3.90 Million | ▲ +8.6 pp |
| 1999 | 1.7% | GBX114.00K | GBX6.57 Million | GBX6.45 Million | — |